In part 3 of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about the heart complication and amputation risks on the greater population.

In part 4 of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about insurance coverage of SGLT-2 drugs and the challenges for patients with heart and kidney issues.

In part 5 of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about studies on the use of SGLT in other populations — people without diabetes, people with kidney disease, etc.

In part 6 of this Exclusive Interview, John Buse compares the Observe 4D study to other similar studies in a conversation with Diabetes in Control Publisher Steve Freed.

In part 7 of this Exclusive Interview, John Buse urges other medical professionals to weigh the risks and benefits of using SGLT in a conversation with Diabetes in Control Publisher Steve Freed.

In part 8, the conclusion of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about the good and bad effects of using SGLT2 for patients who have type 1.

Lisa M. Latts MD, MSPH, MBA, FACP is Deputy Chief Health Officer for IBM Watson Health. She is a national leader in health care quality and has nearly 20 years’ experience in health care delivery working to improve lives for patients.  She has worked as a health insurance executive, a consultant and for one of the nation’s leading academic medical centers helping to deliver high quality care to its faculty and employees. She is currently helping IBM Watson Health bring cognitive computing and machine learning to advance the idea of Value-Based Care and help solve the pressing problems that physicians, employers and payers are facing.

In this Exclusive Interview transcript, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about applications of Watson AI for diabetes care and the benefits for healthcare providers and patients who have diabetes and are taking diabetes medications.

In this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Watson AI and what it can offer to healthcare providers and patients who have diabetes and are taking diabetes medications.

In part 1 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the work done in partnership with the ADA regarding findings among patients with diabetes and their use of medications.